Gastrointestinal dysfunction in diabetic rats relates with a decline in tissue l-arginine content and consequent low levels of nitric oxide

Nitric Oxide - Biology and Chemistry

Volumn 20, Issue 2, 2009, Pages 129-133

  Umathe, S N ^a   Kochar, N I ^a   Jain, N S ^b   Dixit, P V ^a  

^a RTM NAGPUR UNIVERSITY   (India)

^b JL Chaturvedi College of Pharmacy   (India)

Author keywords

c Kit receptor; Diabetic complications; Gastric emptying; l NAME; Nitric oxide synthase; Rats

Indexed keywords

ARGININE; BARIUM SULFATE; ENZYME INHIBITOR; GLUCOSE; NITIC OXIDE SYNTHASE INHIBITOR; NITRIC OXIDE; UNCLASSIFIED DRUG;

AMPEROMETRY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM FUNCTION DISORDER; DIGESTIVE TRACT PARAMETERS; GASTROINTESTINAL TRACT FUNCTION; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERGLYCEMIA; ILEUM; MALE; NONHUMAN; PRIORITY JOURNAL; PYLORUS; RAT; STOMACH EMPTYING;

ANALYSIS OF VARIANCE; ANIMALS; ARGININE; BARIUM SULFATE; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GASTRIC EMPTYING; GASTROINTESTINAL TRANSIT; ILEUM; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PYLORUS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 59349087727     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2008.10.007     Document Type: Article

References (28)

1. Feldman M., and Schiller L.R. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann. Intern. Med. 98 (1983) 378-384
2. Wolosin J.D., and Edelman S.V. Diabetes and the gastrointestinal tract. Clinical diabetes 18 (2000) 148
3. Merio R., Festa A., Bergmann H., Eder T., Eibl N., Stacher-Janotta G., Weber U., Budka C., Heckenberg A., Bauer P., Francesconi M., Schernthaner G., and Stacher G. Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose, and glycemic control. Diabetes Care 20 (1997) 419-423
4. Miller S.M., Narasimhan R.A., Schmalz P.F., Soffer E.E., Walsh R.M., Krishnamurthi V., Pasricha P.J., Szurszewski J.H., and Farrugia G. Distribution of interstitial cells of Cajal and nitrergic neurons in normal and diabetic human appendix. Neurogastroenterol. Motil. 20 (2008) 349-357
5. Choi K.M., Gibbons S.J., Roeder J.L., Lurken M.S., Zhu J., Wouters M.M., Miller S.M., Szurszewski J.H., and Farrugia G. Regulation of interstitial cells of Cajal in the mouse gastric body by neuronal nitric oxide. Neurogastroenterol. Motil. 19 (2007) 585-595
6. Huang P.L., Dawson T.M., Bredt D.S., Snyder S.H., and Fishman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75 (1993) 1273-1286
7. Plourde V., Quintero E., Suto G., Coimbra C., and Tache Y. Delayed gastric emptying induced by inhibitors of nitric oxide synthase in rats. Eur. J. Pharmacol. 256 (1994) 125-129
8. De Winter B.Y., Bredenoord A.J., De Man J.G., Moreels T.G., Herman A.G., and Pelckmans P.A. Effect of inhibition of inducible nitric oxide synthase and guanylyl cyclase on endotoxin-induced delay in gastric emptying and intestinal transit in mice. Shock 18 (2002) 125-131
9. Korenaga K., Micci M.A., Taglialatela G., and Pasricha P.J. Suppression of nNOS expression in rat enteric neurones by the receptor for advanced glycation end-products. Neurogastroenterol. Motil. 18 (2006) 392-400
10. Appleton J. Arginine: clinical potential of a semi-essential amino acid. Altern. Med. Rev. 7 (2002) 512-522
11. Pieper G.M., and Dondlinger L.A. Plasma and vascular tissue arginine are decreased in diabetes: acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production. J. Pharmacol. Exp. Ther. 283 (1997) 684-691
12. Khaidar A., Marx M., Lubec B., and Lubec G. l-Arginine reduces heart collagen accumulation in the diabetic db/db mouse. Circulation 90 (1994) 479-483
13. El-Missiry M.A., Othman A.I., and Amer M.A. l-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus. J. Appl. Toxicol. 24 (2004) 93-97
14. Regensteiner J.G., Popylisen S., Bauer T.A., Lindenfeld J., Gill E., Smith S., Oliver-Pickett C.K., Reusch J.E., and Weil J.V. Oral l-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes. Vasc. Med. 8 (2003) 169-175
15. Sorg D.A., and Buckner B. A simple method of obtaining venous blood from small laboratory animals. Proc. Soc. Exp. Biol. Med. 115 (1964) 1131-1132
16. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol. 22 (1969) 158-161
17. Pestel S., Martin H.J., Maier G.M., and Guth B. Effect of commonly used vehicles on gastrointestinal, renal, and liver function in rats. J. Pharmacol. Toxicol. Methods 54 (2006) 200-214
18. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
19. Boo Y.C., Tressel S.L., and Jo H. An improved method to measure nitrate/nitrite with an NO-selective electrochemical sensor. Nitric Oxide 16 (2007) 306-312
20. Sastry K.V., Moudgal R.P., Mohan J., Tyagi J.S., and Rao G.S. Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal. Biochem. 306 (2002) 79-82
21. Vallance P., Leone A., Calver A., Collier J., and Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J. Cardiovasc. Pharmacol. 20 (1992) S60-S62
22. Beltowski J., and Kêdra A. Asymmetric dimethylarginine (ADMA) as a target for Pharmacotherapy. Pharmacol. Rep. 58 (2006) 159-178
23. Durante W., Johnson F.K., and Johnson R.A. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin. Exp. Pharmacol. Physiol. 34 (2007) 906-911
24. Mohamadin A.M., Hammad L.N., El-Bab M.F., and Gawad H.S. Can nitric oxide-generating compounds improve the oxidative stress response in experimentally diabetic rats?. Clin. Exp. Pharmacol. Physiol. 34 (2007) 586-593
25. Mendez J.D., and Arreola M.A. Effect of l-arginine on pancreatic arginase activity and polyamines in alloxan treated rats. Biochem. Int. 28 (1992) 569-575
26. Vasilijevic A., Buzadzic B., Korac A., Petrovic V., Jankovic A., and Korac B. Beneficial effects of l-arginine nitric oxide-producing pathway in rats treated with alloxan. J. Physiol. 584 (2007) 921-933
27. Sanders K.M., Oè Rdoè G T., Koh S.D., Torihashi S., and Ward S.M. Development and plasticity of interstitial cells of Cajal. Neurogastroenterol. Motil. 11 (1999) 311-338
28. Ördög T., Takayama I., Kwok W., Cheung T., Ward S.M., and Sanders K.M. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes 49 (2000) 1731-1739